Stem cells for Stargardt's Macular Dystrophy

- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Progress Made in Treating Stargardt’s and Dry AMD Using Embryonic Stem Cells

Posted By Irv Arons On January 12, 2012 @ 5:30 am In Clinical Trials,Consultant Articles,Industry News,Macular Degeneration,NeuroOphthalmology,New Technologies,Research,Retina,Stem Cell Therapies | Comments Disabled

Advanced Cell Technology today announced updated information on their three clinical trials underway to treat Stargardt’s Macular Dystrophy (at UCLA’s Jules Stein Eye Institute and at Moorfield’s Eye Hospital) and to treat the dry form of AMD also at Jules Stein.

The first two patients have received embryonic stem cell derived retinal pigment epithelial cells (hESC-derived RPE) and the company has been authorized to treat the next two patients in the UCLA study, while the first patient will be treated in the UK study in the upcoming week(s), while additional patients will be treated at UCLA in the same time frame.

To read more about these groundbreaking studies please follow this link ^[1].

Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/006410-progress-made-in-treating-stargardt%e2%80%99s-and-dry-amd-using-embryonic-stem-cells/

URLs in this post:

[1] link: http://tinyurl.com/ophthstemcells-update13

Click here to print.